An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment
Conditions:   Hepatitis B, Chronic;   Lipid Disorder Interventions:   Drug: oral Tenofovir Amibufenamide 25mg each day;   Drug: lipid lowering drugs (e.g. Atorvastatin and amlodipine.) Sponsor:   Wuhan Union Hospital, China Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2022 Category: Research Source Type: clinical trials

Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients
Condition:   Hyperlipidemias Interventions:   Drug: Zinc sulfate;   Drug: Placebo Sponsor:   Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2022 Category: Research Source Type: clinical trials